Deep Learning on Hyperspectral Pathology for Recurrence Prediction in Clear Cell Renal Cell Carcinoma
Journal of Biophotonics · 2026
DOI: 10.1002/jbio.202500546 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biophotonics, 2026. Verfasst von Xulei Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Institu…. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Deep Learning, Kidney Neoplasms, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: Taishan Scholars Program of Shandong Province, Natural Science Foundation of Shandong Province Youth Project, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Clear cell renal cell carcinoma (ccRCC), the most common aggressive renal cancer subtype, shows marked heterogeneity that hinders recurrence prediction.
Objective
To evaluate hyperspectral pathology imaging (HSI) with deep learning for individualized recurrence risk prediction in ccRCC.
Methods
Slides from 48 patients with ccRCC were imaged using a 400–1000 nm hyperspectral microscope. Spectral data were preprocessed, and a dual‐branch network (HSI‐FusionNet) extracted spatial and spectral features via 2D and 1D convolution, followed by gated fusion and multiple instance learning (MIL) for patient‐level prediction.
Results
HSI‐FusionNet achieved strong test performance (area under the receiver operating characteristic curve [AUC] = 0.912; sensitivity = 0.881; specificity = 0.846), outperforming ResNet‐50, 1D‐Convolutional Neural Network (CNN), and a 1D‐Transformer. Recurrence‐related spectral bands (530–580 and 830–900 nm) reflected hemoglobin and lipid–collagen differences.
Conclusion
HSI with deep learning accurately identifies recurrent ccRCC and reveals molecular–metabolic signatures, supporting precision postoperative risk stratification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Institute of Nephrology, Jinan, China.
- Department of Urology, Shandong Provincial Qianfoshan Hospital, Shandong University Cheeloo College of Medicine, Jinan, China.
- Department of General Surgery, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, China.
- Department of Urology, Zibo Zhoucun People's Hospital, Zibo, China.
ORCID-Profile: Jianning Wang
Förderung
- Taishan Scholars Program of Shandong Province
- Natural Science Foundation of Shandong Province Youth Project
- National Natural Science Foundation of China
Zitieren
APA
Wang, X., Tian, W., Zhao, Y., He, Y., Zhang, Z., Shao, X., Wang, Y., & Wang, J. (2026). Deep Learning on Hyperspectral Pathology for Recurrence Prediction in Clear Cell Renal Cell Carcinoma. Journal of Biophotonics. https://doi.org/10.1002/jbio.202500546
Vancouver
Wang X, Tian W, Zhao Y, He Y, Zhang Z, Shao X, et al. Deep Learning on Hyperspectral Pathology for Recurrence Prediction in Clear Cell Renal Cell Carcinoma. Journal of Biophotonics. 2026. doi:10.1002/jbio.202500546
BibTeX
@article{Wang2026,
author = {Wang, Xulei and Tian, Wenshi and Zhao, Yihan and He, Yihui and Zhang, Zhengyang and Shao, Xiaobo and Wang, Yunchao and Wang, Jianning},
title = {Deep Learning on Hyperspectral Pathology for Recurrence Prediction in Clear Cell Renal Cell Carcinoma},
journal = {Journal of Biophotonics},
year = {2026},
doi = {10.1002/jbio.202500546}
}
EUVIMED